A
Novel Thought?
Hospital turns toward service
Response prepared to national medical errors report
Volume 24 • No. 5 • MAY 2000
We
hope that each of you will make this your personal column.
We are interested in accomplishments, honors or other news involving members
of the medical staff or the Medical Center community. Please tell us about
your friends and colleagues. Or tell us about yourself. Send your contributions
(they don't need to be neat or typed) to Mike Goodkind, Update,
Stanford Medical Center Office of News and Public Affairs, 701 Welch Road,
Suite 2207, Palo Alto, CA 94304. Or contact him at (650) 725-5376 or 723-6911,
by fax at 723-7172, or by e-mail
goodkind@leland.stanford.edu.
RUSS B. ALTMAN, associate professor
of medicine and, by courtesy, of computer science, is Stanford's principal
investigator in a multicenter National Institutes of Health study that
will provide the medical center more than $9 million during the next five
years to host and operate the Stanford Pharmocogenetics Knowledge Base.
The base, announced April 4, will house the shared information for all
scientists in the network, which will focus on how variations in particular
genes influence the body's response to medicines.
GEORGE H. KOENIG, clinical associate professor of neurosurgery in practice in Redwood City and Palo Alto, received the James C. MacLaggan award for medical-political action at the March annual meeting of the California Medical Association (CMA). He is chairman of the CMA's Professional Liability Committee and is currently president-elect of the Sequoia Hospital medical staff.
ROBERT ROBBINS, director of the Heart, Heart-Lung and Lung Transplant Program and an assistant professor of cardiothoracic surgery, has been appointed to the board of directors of Palo Alto-based Cohesion Technologies Inc., developer of resorbable biodevices and delivery systems.
JAMES FORD, assistant professor of medicine and of genetics, has received a New Investigator Award in the Toxicological and Pharmacological Sciences from the Burroughs Wellcome Fund. He will receive $210,000 over three years to study "Transcriptional Regulation of Damage-inducible DNA repair Genes."
DANIEL BERNSTEIN, associate professor of pediatrics and chief of the Division of Pediatric Cardiology, has been elected vice president and president-elect of the 2,600-member Society for Pediatric Research. He will begin service in the SPR's top spot in fall 2001.
PHYLLIS A. DENNERY, associate professor of pediatrics and associate chief in the Division of Neonatal and Developmental Medicine, has been elected secretary-treasurer of the Society for Pediatric Research. For a five-year term starting in fall 2001 - after a year as secretary-treasurer-elect - she will oversee society business matters and participate in the council that plans the annual meeting and offers strategic planning for the society.
JANICE (WES) BROWN, assistant professor of medicine, is the recipient of the first American Society for Bone Marrow Transplantation/ Roche Laboratories New Investigator Award. She received her award to study enhancement of the immune system during and after bone marrow transplantation.
LINDA C. GIUDICE, chief of reproductive endocrinology and infertility and professor of gynecology and obstetrics, has been elected vice president of the Society of Reproductive Endocrinology and Infertility Inc. She is slated to assume the organization's presidency in 2003.
PAUL YOCK, professor of cardiovascular medicine, spoke on the importance of academic and industry connections for technology development and transfer to the public domain at the California Healthcare Institute's "Policy Perspective" luncheon on April 24.
ROBERT J. GLASER, dean of the School of Medicine from 1965 to 1970, founding president of the Institute of Medicine and more recently (1984-1987) director for medical science of the Lucille P. Markey Charitable Trust, has received the John Stearns Award for Lifetime Achievement in Medicine at the meeting of the New York Academy of Medicine on April 18.
